Schedule 13D ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: 2017-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,858,569
- Percent of class
- 13.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-17-000885
- Form type
- SC 13D
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Mar 03, 2017
- Reporting period
- Feb 28, 2017
- Description
- Schedule 13D beneficial ownership